Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial

Iglesias, Juan Fernando; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas

doi:10.1016/j.jcin.2020.07.038

Article scientifique

Lettre

Accès libre

Anglais

Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial

Contributeurs/tricesIglesias, Juan Fernando; Muller, Olivier; Losdat, Sylvain; Roffi, Marco; Kurz, David J; Weilenmann, Daniel; Kaiser, Christoph; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas

Publié dansJACC. Cardiovascular interventions, vol. 13, no. 19, p. 2314-2316

Date de publication2020-10-12

Mots-clés

Absorbable Implants
Coronary Artery Disease / therapy
Drug-Eluting Stents
Everolimus
Humans
Percutaneous Coronary Intervention
Prosthesis Design
Sirolimus
Treatment Outcome

Structure d'affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (format ISO)

IGLESIAS, Juan Fernando et al. Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial. In: JACC. Cardiovascular interventions, 2020, vol. 13, n° 19, p. 2314–2316. doi: 10.1016/j.jcin.2020.07.038

Article (Published version)

OA OTHER

Identifiants

PID : unige:161613
DOI : 10.1016/j.jcin.2020.07.038
PMID : 33032722

ISSN du journal1876-7605

70vues

18téléchargements

Création2022-02-21 15:34:00

Première validation2022-02-21 15:34:00

Heure de mise à jour2023-03-16 06:49:58

Changement de statut2023-03-16 06:49:57

Dernière indexation2024-02-12 13:40:42

Archive ouverte UNIGE

Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial

Informations techniques